Stage IV advanced diffuse large B-cell lymphoma in human immunodeficiency virus infection with achieving cure by using highly active antiretroviral therapy ... DH Lim,JY Rhee,KW Park - 《International Journal of Std & Aids》 被引量: 0发表: 2017年 Prolonged survival of an HIV‐infected patient...
This letter published in the Blood Cancer Journal discusses limited stage high-grade B-cell lymphoma with MYC, BCL2, and/or BCL6 rearrangements. The authors conducted a retrospective analysis of patients with this lymphoma and found that intensive chemotherapy and R-CHOP had similar survival rates...
展开 关键词: lymphoma large B-cell diffuse/drug therapy vincristine/administration & dosage doxorubicin/administration & dosage antibodies monoclonal/therapeutic use antineoplastic combined chemotherapy protocols/therapeutic use treatment outcome survival rate 被引量: 1 年份...
In a series of 193 patients with advanced stage diffuse large-cell lymphoma (DLCL) treated with MACOP-B, 18 (11%) were defined as having a stage II large B-cell lymphoma with sclerosis of the mediastinum. This type of lymphoma has been reported to have a highly aggressive behaviour and ...
RAHWAY, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the Phase 3 KEYNOTE-522 trial evaluating KEYTRUDA, Merck’s anti-PD-1 therapy, met its overall ...
In 1,306 stage IV patients, females also exhibited an advantage in DSS (2-year survival rate, 14.1% v 19.0%; adjusted HR, 0.81; 95% CI, 0.72 to 0.92) as well as for progression-free survival (adjusted HR, 0.79; 95% CI, 0.70 to 0.88). This female advantage was consistent across ...
We assessed stage-specific trends in primary therapy and relative survival among adult follicular lymphoma (FL) patients diagnosed in the Netherlands between 1989–2016 (N = 12,372; median age, 62 years; and 21% stage I disease). Patients were stratified by disease stage and subsequently ...
STAGE IV MARGINAL ZONE B-CELL LYMPHOMA- DO THEY HAVE DIFFERENT PROGNOSIS? AND, HOW TO IMPROVE ROLE OF CHEMOTHERAPY: CONSORTIUM FOR IMPROVING SURVIVAL OF LY... AND, HOW TO IMPROVE ROLE OF CHEMOTHERAPY: CONSORTIUM FOR IMPROVING SURVIVAL OF LYMPHOMA (CISL) STUDYdoi:10.1586/EHM.10.12blood thinners...
Predictive value of 18F-FDG PET and CT morphologic features for recurrence in pathological stage IA non-small cell lung cancer. Med (Baltim). 2015;94(3):e434. Article CAS Google Scholar Albano D, Giubbini R, Bertagna F. 18F-FDG PET/CT in splenic marginal zone lymphoma. Abdom Radiol ...
From July 1990 to March 1996, 112 children with stage III or IV B-cell non-Hodgkin's lymphoma (B-NHL) with up to 70% FAB L3-type blasts (n= 42) in the bone marrow without central nervous system (CNS) disease were treated on the United Kingdom Children Cancer Study Group (UKCCSG)...